PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 4.757
EU - Europa 3.344
AS - Asia 2.515
OC - Oceania 341
SA - Sud America 180
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.267
Nazione #
US - Stati Uniti d'America 4.527
CN - Cina 998
GB - Regno Unito 765
IT - Italia 637
FR - Francia 538
JP - Giappone 316
AU - Australia 262
IN - India 243
DE - Germania 229
CA - Canada 196
SE - Svezia 187
ES - Italia 186
NL - Olanda 156
VN - Vietnam 135
TW - Taiwan 130
HK - Hong Kong 114
KR - Corea 94
BR - Brasile 84
NZ - Nuova Zelanda 79
RU - Federazione Russa 68
IE - Irlanda 61
CZ - Repubblica Ceca 55
ID - Indonesia 53
TH - Thailandia 53
BE - Belgio 51
PK - Pakistan 50
PL - Polonia 48
SG - Singapore 46
PT - Portogallo 45
TR - Turchia 42
PH - Filippine 41
UA - Ucraina 40
MY - Malesia 39
ZA - Sudafrica 39
CO - Colombia 36
IR - Iran 35
GR - Grecia 33
RO - Romania 33
EG - Egitto 30
FI - Finlandia 30
MX - Messico 29
SA - Arabia Saudita 29
AE - Emirati Arabi Uniti 28
PE - Perù 26
SK - Slovacchia (Repubblica Slovacca) 26
CH - Svizzera 25
CL - Cile 22
DK - Danimarca 18
MK - Macedonia 18
IL - Israele 15
AT - Austria 13
KE - Kenya 13
RS - Serbia 13
NO - Norvegia 12
BD - Bangladesh 11
BG - Bulgaria 11
HU - Ungheria 11
HR - Croazia 9
QA - Qatar 9
DZ - Algeria 8
ET - Etiopia 8
MA - Marocco 7
EC - Ecuador 6
LU - Lussemburgo 6
UZ - Uzbekistan 6
KW - Kuwait 5
LT - Lituania 5
CM - Camerun 4
IQ - Iraq 4
SI - Slovenia 4
TN - Tunisia 4
AL - Albania 3
AR - Argentina 3
CR - Costa Rica 3
KZ - Kazakistan 3
LB - Libano 3
MT - Malta 3
NG - Nigeria 3
BA - Bosnia-Erzegovina 2
JO - Giordania 2
LK - Sri Lanka 2
LY - Libia 2
NP - Nepal 2
SC - Seychelles 2
SO - Somalia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EU - Europa 1
GH - Ghana 1
JE - Jersey 1
KH - Cambogia 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
Totale 11.261
Città #
Santa Cruz 664
Ashburn 381
Fairfield 252
Houston 179
Des Moines 176
Seattle 171
Shanghai 152
Woodbridge 133
Buffalo 106
Chicago 99
Ann Arbor 98
Dong Ket 98
London 97
Beijing 90
Ferrara 89
Stockholm 84
Taipei 81
Cambridge 78
Central 71
Sydney 66
Wilmington 64
Guangzhou 63
Los Angeles 61
Paris 61
San Diego 61
New York 60
Tokyo 55
Melbourne 51
Hebei 50
Dublin 47
Boardman 43
Toronto 43
Birmingham 42
Shenyang 42
Rome 40
Auckland 39
Barcelona 39
Madrid 38
Hangzhou 36
Milan 36
Manchester 34
São Paulo 34
Utrecht 34
Warsaw 33
Las Vegas 32
Dallas 31
Cardiff 30
Chennai 28
Brisbane 27
Singapore 26
Chengdu 25
Mumbai 25
Bangkok 24
Bologna 24
Nanjing 23
Lake Forest 22
Seoul 22
Changsha 21
Helsinki 21
Kuala Lumpur 21
Saint Petersburg 21
Bengaluru 20
Bratislava 20
San Francisco 20
Wuhan 20
Bogotá 19
Cedar Knolls 19
Hanoi 19
San Jose 19
Padova 18
Chongqing 17
Henderson 17
Karachi 17
Philadelphia 17
Atlanta 16
Hamburg 16
Munich 16
New Delhi 16
Provo 16
Cairo 15
Frankfurt am Main 15
Hyderabad 15
Perth 15
St Louis 15
Taichung 15
Zhengzhou 15
Amsterdam 14
Boston 14
Islington 14
Otemae 14
Oxford 14
Riyadh 14
Bhopal 13
Bradford 13
Duncan 13
Durham 13
Milford Haven 13
Osaka 13
Ottawa 13
Santiago 13
Totale 5.309
Nome #
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial, file e309ade2-d568-3969-e053-3a05fe0a2c94 1.312
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study, file e309ade3-b15a-3969-e053-3a05fe0a2c94 1.093
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial, file e309ade2-d573-3969-e053-3a05fe0a2c94 938
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial, file e309ade4-becd-3969-e053-3a05fe0a2c94 771
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials, file e309ade4-7f67-3969-e053-3a05fe0a2c94 344
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-e7e4-3969-e053-3a05fe0a2c94 332
Controlled trial of budesonide-formoterol as needed for mild asthma, file e309ade2-cf33-3969-e053-3a05fe0a2c94 310
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial, file e309ade4-82cd-3969-e053-3a05fe0a2c94 279
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial, file e309ade2-d388-3969-e053-3a05fe0a2c94 243
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6, file 02d33c64-6dec-4ebf-a439-a19c7c98aa43 211
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma, file e309ade4-c029-3969-e053-3a05fe0a2c94 179
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma, file e309ade4-7604-3969-e053-3a05fe0a2c94 176
Inhaled corticosteroids in COPD: Friend or foe?, file e309ade3-49d4-3969-e053-3a05fe0a2c94 156
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies, file e309ade4-a288-3969-e053-3a05fe0a2c94 149
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells, file e309ade2-d027-3969-e053-3a05fe0a2c94 135
Extrafine triple therapy in patients with asthma and persistent airflow limitation, file e309ade4-6f73-3969-e053-3a05fe0a2c94 130
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma, file e309ade4-8db0-3969-e053-3a05fe0a2c94 123
Efficacy and Safety of treatment with dupilumab for severe asthma: a systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma, file e309ade4-6c79-3969-e053-3a05fe0a2c94 103
Use of mucolytics in COPD: A Delphi consensus study, file e309ade4-cb1f-3969-e053-3a05fe0a2c94 94
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program, file e309ade4-6bfc-3969-e053-3a05fe0a2c94 87
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review, file e309ade2-c7fc-3969-e053-3a05fe0a2c94 86
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD, file e309ade2-d1c5-3969-e053-3a05fe0a2c94 86
Clinical and Pathologic Factors Predicting Future Asthma in Wheezing Children. A Longitudinal Study, file e309ade4-cd17-3969-e053-3a05fe0a2c94 83
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium, file e309ade4-b8c5-3969-e053-3a05fe0a2c94 77
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI guidelines - recommendations on the use of biologicals in severe asthma, file e309ade4-8b10-3969-e053-3a05fe0a2c94 72
Benralizumab for the prevention of COPD exacerbations, file e309ade4-cd8f-3969-e053-3a05fe0a2c94 72
Caring for patients with COPD and COVID-19: a viewpoint to spark discussion, file e309ade4-862b-3969-e053-3a05fe0a2c94 69
Burden of Pertussis in COPD: A Retrospective Database Study in England, file e309ade4-4eff-3969-e053-3a05fe0a2c94 68
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee, file e309ade4-73c2-3969-e053-3a05fe0a2c94 65
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis, file e309ade4-7f80-3969-e053-3a05fe0a2c94 64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease, file e309ade2-d56b-3969-e053-3a05fe0a2c94 63
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis, file e309ade4-9727-3969-e053-3a05fe0a2c94 57
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline, file e309ade3-b15e-3969-e053-3a05fe0a2c94 55
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal, file e309ade4-aef3-3969-e053-3a05fe0a2c94 54
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases, file e309ade4-f59c-3969-e053-3a05fe0a2c94 53
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation, file e309ade3-4251-3969-e053-3a05fe0a2c94 52
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019, file e309ade3-f58a-3969-e053-3a05fe0a2c94 52
Prevention of COPD exacerbations: A European Respiratory Society/ American Thoracic Society guideline, file e309ade4-9724-3969-e053-3a05fe0a2c94 52
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer, file e309ade2-a3c7-3969-e053-3a05fe0a2c94 51
SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries, file e309ade4-72bb-3969-e053-3a05fe0a2c94 51
Triple therapy in COPD: New evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide, file e309ade4-ab2a-3969-e053-3a05fe0a2c94 51
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma, file e309ade4-c022-3969-e053-3a05fe0a2c94 51
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules, file e309ade4-c4b7-3969-e053-3a05fe0a2c94 51
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations, file e309ade2-b996-3969-e053-3a05fe0a2c94 50
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting, file e309ade4-1ae1-3969-e053-3a05fe0a2c94 50
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: Meta-analysis of MENSA and MUSCA, file e309ade4-9fa8-3969-e053-3a05fe0a2c94 50
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA, file e309ade4-a3f6-3969-e053-3a05fe0a2c94 50
Asthma COPD Overlap PRO-CON Debate. ACO: The Mistaken Term, file e309ade4-ab4c-3969-e053-3a05fe0a2c94 50
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis, file e309ade0-2ded-3969-e053-3a05fe0a2c94 49
A multinational observational study identifying primary care patients at risk of overestimation of asthma control, file e309ade4-701a-3969-e053-3a05fe0a2c94 49
Inhaled corticosteroid containing combinations and mortality in COPD, file e309ade4-b0ad-3969-e053-3a05fe0a2c94 49
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO), file e309ade4-b409-3969-e053-3a05fe0a2c94 49
Blood eosinophil count and exacerbation risk in patients with COPD, file e309ade4-b54a-3969-e053-3a05fe0a2c94 49
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma, file e309ade0-2dec-3969-e053-3a05fe0a2c94 48
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial, file e309ade4-8490-3969-e053-3a05fe0a2c94 48
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma, file e309ade4-d2a9-3969-e053-3a05fe0a2c94 48
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial, file e309ade4-1651-3969-e053-3a05fe0a2c94 47
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD, file e309ade2-c7cc-3969-e053-3a05fe0a2c94 46
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD, file e309ade4-7ea1-3969-e053-3a05fe0a2c94 46
Asthma progression and mortality: The role of inhaled corticosteroids, file e309ade4-a2ba-3969-e053-3a05fe0a2c94 46
The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision, file e309ade4-bb90-3969-e053-3a05fe0a2c94 46
Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study, file e309ade4-c737-3969-e053-3a05fe0a2c94 46
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure, file e309ade4-d385-3969-e053-3a05fe0a2c94 46
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD, file e309ade3-480e-3969-e053-3a05fe0a2c94 45
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians, file e309ade4-7fe8-3969-e053-3a05fe0a2c94 45
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD, file e309ade4-afe4-3969-e053-3a05fe0a2c94 45
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis, file e309ade4-3cc2-3969-e053-3a05fe0a2c94 44
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD, file e309ade4-a4f5-3969-e053-3a05fe0a2c94 44
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD, file e309ade0-8555-3969-e053-3a05fe0a2c94 43
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline, file e309ade3-b15f-3969-e053-3a05fe0a2c94 43
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease, file e309ade4-4f05-3969-e053-3a05fe0a2c94 43
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma, file e309ade4-c730-3969-e053-3a05fe0a2c94 43
From Gold 0 to Pre-COPD, file e309ade4-102a-3969-e053-3a05fe0a2c94 42
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease, file e309ade4-913f-3969-e053-3a05fe0a2c94 42
Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease, file e309ade4-f6de-3969-e053-3a05fe0a2c94 42
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation, file e309ade0-ce14-3969-e053-3a05fe0a2c94 41
Treatment strategies for asthma: Reshaping the concept of asthma management, file e309ade4-6b97-3969-e053-3a05fe0a2c94 41
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol, file e309ade4-c46e-3969-e053-3a05fe0a2c94 41
Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative, file e309ade4-c9c3-3969-e053-3a05fe0a2c94 41
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function, file e309ade4-d4a8-3969-e053-3a05fe0a2c94 40
New drugs targeting Th2 lymphocytes in asthma, file e309ade5-0962-3969-e053-3a05fe0a2c94 40
Ectopic thymoma simulating a pericardial cyst: case report, file e309ade0-2bea-3969-e053-3a05fe0a2c94 39
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study, file e309ade4-6f51-3969-e053-3a05fe0a2c94 39
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease, file e309ade4-8e73-3969-e053-3a05fe0a2c94 39
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions, file e309ade4-b185-3969-e053-3a05fe0a2c94 39
Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER, file e309ade4-bb92-3969-e053-3a05fe0a2c94 39
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy, file e309ade5-0ab3-3969-e053-3a05fe0a2c94 39
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD, file e309ade4-a6ab-3969-e053-3a05fe0a2c94 38
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy, file e309ade4-af6d-3969-e053-3a05fe0a2c94 38
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma, file e309ade5-097b-3969-e053-3a05fe0a2c94 38
The burden of self-reported rhinitis and associated risk for exacerbations with moderate-severe asthma in primary care patients, file e309ade4-a3aa-3969-e053-3a05fe0a2c94 37
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies, file e309ade4-dd19-3969-e053-3a05fe0a2c94 37
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients, file e309ade4-f573-3969-e053-3a05fe0a2c94 36
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study, file e309ade5-209c-3969-e053-3a05fe0a2c94 36
Inhaled triple therapy in chronic obstructive pulmonary disease – Authors' reply, file e309ade5-1d96-3969-e053-3a05fe0a2c94 34
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study, file e309ade4-8935-3969-e053-3a05fe0a2c94 32
Effects of anti-IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real-life multicentre study (BIONIGE), file 46a8c934-c458-4122-90a9-0ac123b4779c 24
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal, file d8d8ff24-e8dd-4f11-a365-7b33ac20f98e 24
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease, file 31219c79-38ba-4144-95df-3d2ae06d23ae 22
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-e7e5-3969-e053-3a05fe0a2c94 21
Totale 10.978
Categoria #
all - tutte 33.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 1 0 0 0 1 0 0 0 0 0 0 0
2020/20211.268 0 0 0 7 70 88 96 102 102 169 280 354
2021/20223.307 158 160 164 284 337 222 200 215 279 202 723 363
2022/20233.841 154 218 721 442 201 280 307 227 274 373 358 286
2023/20243.058 280 287 299 270 325 362 279 367 374 215 0 0
Totale 11.489